All 1 tracked stories fall under one category: market-trends. Arcosa is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 5 original sources per story, versus 3.2 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.7 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about MasTec
All 1 tracked stories fall under one category: market-trends. Arcosa is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 5 original sources per story, versus 3.2 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.7 for that window. We currently track 1 Healthcare story that mention MasTec, all published on February 27, 2026.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering MasTec. Shared-story counts are live from our verified record — not editorial picks.
Concentra (CON) reported a significant climb in Q4 2025 profits, driven by a surge in patient volume and the continued integration of digital health platforms. The company's performance reflects a broader recovery in the industrial and infrastructure sectors, which serve as primary drivers for occupational health demand.
MasTec is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.